Department of Medicine, Keck School of Medicine of the University of Southern California.
Division of Cardiovascular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
Curr Opin Organ Transplant. 2022 Feb 1;27(1):36-44. doi: 10.1097/MOT.0000000000000943.
Heart failure incidence continues to rise despite a relatively static number of available donor hearts. Selecting an appropriate heart transplant candidate requires evaluation of numerous factors to balance patient benefit while maximizing the utility of scarce donor hearts. Recent research has provided new insights into refining recipient risk assessment, providing additional tools to further define and balance risk when considering heart transplantation.
Recent publications have developed models to assist in risk stratifying potential heart transplant recipients based on cardiac and noncardiac factors. These studies provide additional tools to assist clinicians in balancing individual risk and benefit of heart transplantation in the context of a limited donor organ supply.
The primary goal of heart transplantation is to improve survival and maximize quality of life. To meet this goal, a careful assessment of patient-specific risks is essential. The optimal approach to patient selection relies on integrating recent prognostication models with a multifactorial assessment of established clinical characteristics, comorbidities and psychosocial factors.
尽管可供使用的供体心脏数量相对稳定,但心力衰竭的发病率仍在持续上升。选择合适的心脏移植候选人需要评估众多因素,在平衡患者获益的同时最大限度地提高稀缺供体心脏的利用率。最近的研究为完善受者风险评估提供了新的见解,提供了额外的工具来进一步定义和平衡考虑心脏移植时的风险。
最近的出版物已经开发出模型,以协助根据心脏和非心脏因素对潜在的心脏移植受者进行风险分层。这些研究为临床医生在有限的供体器官供应的情况下平衡心脏移植的个体风险和获益提供了额外的工具。
心脏移植的主要目的是提高生存率和最大限度地提高生活质量。为了达到这个目标,对患者特定风险进行仔细评估是至关重要的。最佳的患者选择方法依赖于将最近的预后模型与既定临床特征、合并症和社会心理因素的多因素评估相结合。